FREE delivery to all EXCLUSIVE BOOKS stores nationwide. FREE delivery to your door on all orders over R450. Excludes all international deliveries.

Thyroid Cancer

James A. Fagin
    Product form
      FORMAT: Hardback

      R 6,013.33 Price and availability exclusive to website

      YOU COULD EARN 6,013.33 FUTURE RETAIL DISCOUNTS.
      ESTIMATED DELIVERY: Approx. 10 - 15 Business Days
      BUY NOW PAY LATER
      From R 1,002.22 per month!
      3x monthly payments of R 2,004.44 with
      4x fortnightly payments of R 1,503.33 with
      Because of its relative rarity and favorable outcome, it has not been feasible to assess medical interventions for thyroid cancer using randomized prospective trials. The approach to diagnosis and treatment relies to a great extent on information derived from retrospective studies. Overall prognosis and survival rates have been edging upward over the past two decades. This is attributed to a wider acceptance of total thyroidectomy as the primary surgical strategy. The appropriate indication of radioiodine therapy remains controversial, and physicians must be familiar with staging criteria to make educated decisions. We are now beginning to understand the genetic mechanisms of thyroid tumor initiation and progression. There are still major challenges ahead. Thyroid Cancer provides comprehensive updates on the epidemiology, pathogenesis, diagnosis and treatment of thyroid neoplasms. Although the material should be of particular interest to scholars in the field, the contributors have striven to make it of practical use to physicians who treat patients with thyroid disease.
      Format: CONTRIBUTORS: James A. Fagin EAN: 9780792383260 COUNTRY: Netherlands PAGES: WEIGHT: 1560 g HEIGHT: 235 cm
      PUBLISHED BY: Springer DATE PUBLISHED: 1998-12-31 CITY: GENRE: MEDICAL / Endocrinology & Metabolism, MEDICAL / Internal Medicine, MEDICAL / Oncology / General WIDTH: 155 cm SPINE:

      Book Themes:

      Clinical and internal medicine, Diseases and disorders, Oncology

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      Because of its relative rarity and favorable outcome, it has not been feasible to assess medical interventions for thyroid cancer using randomized prospective trials. The approach to diagnosis and treatment relies to a great extent on information derived from retrospective studies. Overall prognosis and survival rates have been edging upward over the past two decades. This is attributed to a wider acceptance of total thyroidectomy as the primary surgical strategy. The appropriate indication of radioiodine therapy remains controversial, and physicians must be familiar with staging criteria to make educated decisions. We are now beginning to understand the genetic mechanisms of thyroid tumor initiation and progression. There are still major challenges ahead. Thyroid Cancer provides comprehensive updates on the epidemiology, pathogenesis, diagnosis and treatment of thyroid neoplasms. Although the material should be of particular interest to scholars in the field, the contributors have striven to make it of practical use to physicians who treat patients with thyroid disease.
      Format: CONTRIBUTORS: James A. Fagin EAN: 9780792383260 COUNTRY: Netherlands PAGES: WEIGHT: 1560 g HEIGHT: 235 cm
      PUBLISHED BY: Springer DATE PUBLISHED: 1998-12-31 CITY: GENRE: MEDICAL / Endocrinology & Metabolism, MEDICAL / Internal Medicine, MEDICAL / Oncology / General WIDTH: 155 cm SPINE:

      Book Themes:

      Clinical and internal medicine, Diseases and disorders, Oncology

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)

      Recently viewed products

      Login

      Forgot your password?

      Don't have an account yet?
      Create account